All companies
Visit website
Vxtra Health
OperatingVixtra Health Plan, Inc.
Healthcare · Technology · Founded 2021
Leveraging over a decade of experience managing healthcare benefits for large medical practices
Post-money valuation ⓘ
$15.4M
As of Aug 2022 · from Vixtra Health Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$207,762
Across 1 round since 2021
Latest share price
$0.40
Vixtra Health Common Stock 1 offering price
Financials
FY2019–FY2021 · from SEC filings · hover any figure for its source$2.0M
$583K
2019
$1.8M
−$74K
2020
$2.0M
−$592K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
Income statement
Revenue
$1,955,097
$1,848,743
$2,049,357
Cost of goods sold
$2,504,346
$0
$0
Gross margin
-28%
100%
100%
Net income
$582,791
-$74,121
-$591,797
Taxes paid
$0
$0
$0
Balance sheet
Cash
$226,740
$136,532
$103,151
Accounts receivable
$110,855
$193,169
$130,868
Total assets
$460,194
$456,768
$237,708
Short-term debt
$793,572
$1,298,010
$688,827
Long-term debt
$435,791
$549,970
$447,808
Total liabilities
$1,229,363
$1,847,980
$1,136,635
Other
Headcount
—
8
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$15.4M
post-money
Vixtra Health Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $207.8K / $5MInvestors 97Post-money $15.4M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 5 annual reports (FY2021–FY2025)
97 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001881925Share price $0.40
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.